☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Gastrointestinal Stromal Tumors
Deciphera Reports the US FDA's Acceptance of NDA and Priority Review for Ripretinib to Treat Patients with Advanced Gastrointestin...
February 13, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.